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icrotubule-dependent transport of vesicles and
organelles appears saltatory because particles
switch between periods of rest, random Brown-
ian motion, and active transport. The transport can be
regulated through motor proteins, cargo adaptors, or
microtubule tracks. We report here a mechanism whereby
microtubule associated proteins (MAPs) represent obstacles
to motors which can be regulated by microtubule afﬁnity
regulating kinase (MARK)/Par-1, a family of kinases that
is known for its involvement in establishing cell polarity
and in phosphorylating tau protein during Alzheimer
M
 
neurodegeneration. Expression of MARK causes the
phosphorylation of MAPs at their KXGS motifs, thereby
detaching MAPs from the microtubules and thus facilitating
the transport of particles. This occurs without impairing
the intrinsic activity of motors because the velocity during
active movement remains unchanged. In primary retinal
ganglion cells, transfection with tau leads to the inhibition
of axonal transport of mitochondria, APP vesicles, and
other cell components which leads to starvation of axons
and vulnerability against stress. This transport inhibition
can be rescued by phosphorylating tau with MARK.
 
Introduction
 
Microtubule-dependent transport by motor proteins is a major
mechanism for distributing vesicles or organelles in the cell.
Examples are endocytosis or exocytosis of vesicles, the distri-
bution of mitochondria or peroxisomes, or the separation of
chromosomes during mitosis (Terada and Hirokawa, 2000;
Kamal and Goldstein, 2002). Active transport is particularly
important when cells become asymmetric (e.g., the axons of
neuronal cells) or when cell components have to be transported
against a concentration gradient (e.g., the RNA-containing
P-granules in zygotes). The tracks are provided by the polar
microtubule network, the motion is generated by motor proteins
with built-in directionality (kinesin usually toward the cell
periphery, “outbound”, dynein toward the cell interior, “inbound”),
and cargoes are attached by adaptor complexes. Given the
crowded interior of a cell, this poses the problem of how the
delivery of cargoes is regulated. Linkage to the right adaptors
and motors is a key decision, but even if that is achieved,
movement in the right direction is not ensured unless an open
path is provided. Here, we are concerned with traffic control by
phosphorylation which has been suspected to contribute to the
regulation. For example, motor proteins can be phosphorylated
and kinases influence vesicle attachment (Lee and Hollenbeck,
1995; Lopez and Sheetz, 1995; Sato-Harada et al., 1996; Morfini
et al., 2002), but the connection between kinases, target proteins,
and motility has remained elusive.
Microtubule tracks are covered with microtubule associ-
ated proteins (MAPs), which contribute to their stabilization
that is important for cell shape or neurite outgrowth (Drubin
and Kirschner, 1986; Kosik and McConlogue, 1994; Cassimeris
and Spittle, 2001; Baas, 2002; Biernat et al., 2002). In addition
MAPs can compete with motors for microtubule binding (Lopez
and Sheetz, 1993; Hagiwara et al., 1994). Our earlier experi-
ments with CHO cells transfected with tau protein revealed an
inhibition of transport, with the consequence that organelles
clustered in the cell interior (Ebneth et al., 1998). Analysis of
organelle flux showed that both types of microtubule motors
(kinesin and dynein) become inhibited by tau, but kinesin is more
affected so that dynein dominates. Furthermore, experiments
with single molecules showed that elevated concentrations of
tau on the microtubule surface leads to a reduced attachment of
kinesin (Seitz et al., 2002). Analysis of the transport inhibition
by tau in neurons showed that the flux of mitochondria and
vesicles containing amyloid precursor protein (APP) down the
axon is disturbed, resulting in the degeneration of the axons
(Stamer et al., 2002). The results suggested a new relationship
between tau and APP, the two proteins which play a key role
in Alzheimer’s disease.
 
The online version of this article contains supplemental material.
Correspondence to Eva Marie Mandelkow: mandelkow@mpasmb.desy.de
B. Trinczek’s present address is Dept. of Medicinal Chemistry, University of
Kansas, Lawrence, KS 66045.
Abbreviations used in this paper: APP, amyloid precursor protein; MAP, micro-
tubule associated protein; MARK, microtubule affinity regulating kinase; RGC,
retinal ganglion cell. 
JCB • VOLUME 167 • NUMBER 1 • 2004 100
 
The kinases and phosphorylation sites of MAPs have
been studied extensively in the context of microtubule stabili-
zation and neurodegeneration, especially for the case of tau
protein (Garcia and Cleveland, 2001; Lee et al., 2001). Certain
kinases are particularly efficient in detaching MAPs from mi-
crotubules; the best examples are the microtubule affinity reg-
ulating kinase (MARK)/Par1 kinases, which phosphorylate
the KXGS motifs in the repeat domains of MAP4, MAP2, or
tau (Drewes et al., 1997). Increasing the activation of MARK
by expression of MARK or its activating kinase MARKK
leads to microtubule breakdown and cell death (Ebneth et al.,
1999; Timm et al., 2003). Homologous kinases (PAR-1) play
a role in cell polarity development (Kemphues, 2000; Riech-
mann and Ephrussi, 2001; Cohen et al., 2004) or in neurite
outgrowth (Biernat et al., 2002). To study the influence of
MAP phosphorylation on vesicle and organelle transport we
used different cell models. We generated CHO cells inducibly
expressing MARK2, labeled vesicles and organelles with fluo-
rescent markers, and traced them by live cell microscopy. To
study the influence of tau phosphorylation on axonal transport
in primary retinal ganglion neurons we transfected them with
YFP-MARK2 and CFP-tau by adenoviruses. Here, we show
that different MAPs have similar inhibitory effects on micro-
tubule-based transport which are relieved by kinases of the
MARK family that reduce the level of microtubule-bound
MAPs and thus remove obstacles from the microtubule sur-
face. In retinal ganglion cells (RGCs) we demonstrate that the
inhibition of axonal transport by tau is rescued by the activity
of MARK2, which phosphorylates tau at the KXGS motifs
and, thus, detaches it from the microtubule tracks. This has
implications for the neurodegeneration in Alzheimer’s disease
where the phosphorylation of tau by kinases of the MARK
family is enhanced.
 
Results
 
Transport inhibition by MAPs
 
MAPs are known as stabilizers of microtubules and promot-
ers of neurite outgrowth. In the case of the neuronal tau pro-
tein another potential function is the regulation of intracellu-
lar traffic (Ebneth et al., 1998). This ability of tau appears to
be rather general, it occurs in all cell types where tau is ex-
pressed, and it affects all cargoes transported along microtu-
bules tested so far (vesicles, organelles, intermediate fila-
Figure 1. Inhibition of plus-end directed transport of mito-
chondria by tau, MAP2c, and MAP4. (a) Untransfected
CHO control cells stained for tubulin (green) and mito-
chondria (MitoTracker, red). Note that mitochondria are
distributed throughout the cell. (b) CHO cell stably trans-
fected with GFP-tau. (c) CHO cells stably transfected with
MAP2c (HA-tagged, blue), (d) stained for tubulin (green)
and mitochondria (red, yellow). (e) CHO cells stably
transfected with MAP4-BD (HA tagged), (f) stained for
tubulin and mitochondria. Note that all MAPs in b–e cause
clustering of mitochondria at the MTOC. 
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ments, etc.). Because tau is a neuronal MAP it was of
particular interest for neurodegeneration in Alzheimer’s dis-
ease where traffic along microtubules is interrupted (Stamer
et al., 2002). However, it was an open question whether other
MAPs in other cell types could affect microtubule transport in
a similar fashion. We addressed this issue by studying MAP2
and MAP4, two major types of MAPs. CHO cells were stably
transfected with MAP2c (the juvenile short isoform of the
neuronal MAP2) or MAP4-BD, the microtubule-binding do-
main of the ubiquitous MAP4 (Olson et al., 1995), and the
transport of vesicles, mitochondria, peroxisomes, or vimentin
intermediate filaments was monitored (Fig. 1). In each case
one observes an inhibition of net outward transport which re-
sults in the clustering of the cargoes in the cell center. In
wild-type cells, mitochondria are distributed throughout the
cytoplasm (Fig. 1 a), but in stably MAP-transfected cells they
congregate around the MTOC (Fig. 1, b, d, and f). This effect
is reminiscent of that of tau and is explained by a general in-
hibition of motor proteins which affects kinesin more than
dynein so that the centripetal movements dominate (Trinczek
et al., 1999). The effect depends on the affinity and concen-
tration of MAPs, i.e., low levels of MAPs or loosely bound
MAP constructs have only little effect on traffic. Because the
binding of MAPs to microtubules is regulated by phosphor-
ylation one would expect that kinases that detach MAPs
from  microtubules would relieve the inhibition of motors.
One kinase family that detaches tau, MAP2, and MAP4 effi-
ciently from microtubules is MARK, which phosphorylates
the KXGS motifs in the repeat domain of these MAPs (Illen-
berger et al., 1996). Thus, a major aim of this work was to
find out whether kinases of the MARK family could indeed
counteract the transport inhibition by MAPs.
Figure 2. Recovery of plus-end transport of mitochondria
by coexpression of tau and MARK2. (a and b) CHO cells
stably expressing tau and cotransfected with YFP-MARK2
(a, yellow and open arrowhead). In cells not expressing
MARK2, mitochondria are clustered around the MTOC
(closed arrowheads, cell perimeters dotted white), whereas
the cell expressing MARK2 (top left) shows redispersion
because the block of transport is partially relieved. (c and d)
Correlation between MARK2 expression and tau phos-
phorylation at KXGS motifs (12E8 antibody). (c) Distribu-
tion of YFP-MARK2 (yellow) and (d) the same cells contain
tau with elevated phosphorylation (green). Arrows point
to untransfected cell not showing phosphorylation of
MARK2 and tau. (e) Comparison of distribution of mito-
chondria. In wild-type CHO cells  50% of the cytoplasm
is populated by mitochondria. The fraction is reduced to
 15% after transfection with tau, but nearly restored af-
ter additional transfection with MARK2. The inactive
MARK2 mutant cannot rescue the clustering caused by tau. 
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MARK relieves transport inhibition 
by MAPs
 
When trying to observe the detachment of MAPs experimen-
tally one is faced with the dual consequences of phosphoryla-
tion by MARK: detachment of MAPs may clear the microtu-
bule tracks and thus facilitate traffic, but bare microtubules are
less stable and tend to disintegrate, thereby interrupting traffic
altogether. In CHO cells (which have a low level of endoge-
nous MAP4), transient transfection with MARK causes the
rapid disintegration of microtubules (with subsequent cell
death), and the level of phospho-MAP4 remains below detect-
ability by immunofluorescence (Ebneth et al., 1999). If these
cells are stably transfected with tau, MAP2c, or MAP4-BD in
order to visualize the inhibition of traffic (e.g., by the clustering
of mitochondria, as in Fig. 1, b, d, and f), microtubules are sta-
bilized and cells remain viable. In this case the transfection of
MARK suffices to make the phosphorylation of MAPs visible
(Fig. 2, c and d; Ebneth et al., 1999). But it has been difficult to
demonstrate how the phosphorylation of MAPs leads to the
reversal of transport inhibition. The reason is that too much
phosphorylation causes not only detachment of MAPs and
clearance of the microtubule tracks, but also breakdown of
microtubules, whereas too little phosphorylation does not res-
cue the transport inhibition. This means that one has to match
the concentration of MAPs with the activity of MARK in a
controlled fashion.
To achieve this we tested different transfection systems,
including a MARK2-inducible cell line (tet-on), to control the
expression and activity of the kinase. The best results were ob-
tained with the adenovirus transfection protocol (He et al.,
1998, Stamer et al., 2002). Because MARK2 was tagged with
YFP and mitochondria with MitoTracker it was possible to
monitor MARK2 and mitochondria simultaneously in living
cells. In the tau-stable CHO cell line mitochondria are clustered
near the MTOC (Fig. 2 b, closed arrowheads), but when the
cells are transfected with MARK2 the mitochondria become
dispersed again (Fig. 2 b, open arrowheads). The expression of
MARK2 is accompanied by strong enhancement of tau phos-
phorylation at the KXGS motifs (Fig. 2, c and d, 12E8 anti-
body), consistent with tau’s detachment from microtubules and
the release of the traffic blockade. Thus, MARK and tau oper-
ate in an antagonistic fashion. Quantification shows that 
 
 
 
50%
of the cytoplasm is occupied by mitochondria in control cells,
which decreases to 
 
 
 
15% after tau transfection. The traffic
blockade can be relieved by MARK2, but not by the kinase-
dead MARK2 mutant (Fig. 2 e).
 
MARK facilitates endogenous traffic 
in cells
 
Our next aim was to monitor the movement of vesicles or or-
ganelles along microtubules and to record the parameters of
speed, run length, changes in direction, and how they depend
on kinases such as MARK. To test whether the phosphorylation
of MAPs and their detachment from microtubules would lead
to changes in mobility we expressed MARK2 in a controlled
fashion in CHO cells under the inducible tet-on expression pro-
tocol (Gossen and Bujard, 2002) and chose early time points of
Figure 3. Motion analysis of vesicles and organelles. MARK2 is expressed
inducibly in CHO cells under the control of the tetracycline responsive
promoter. (a) Upon induction with 1  g/ml doxycyclin for 12–18 h,
HA-tagged MARK2 becomes detectable by the polyclonal rabbit HA-tag
antibody in the cells ( 100% in the induced state). Because prolonged
periods of MARK expression (24–72 h) destroy the microtubule network
the motility assays were done at earlier time points where  90% of cells
have normal microtubules and the MTOC is preserved. (b) Immunofluores-
cence of cells by anti-tubulin antibody DM1A showing that most cells are
HA-MARK positive (a) and have a normal microtubule network. (c) The
movement of an individual vesicle (arrowheads) was recorded during a
period of 60 s (shown in 5-s intervals). TGN identifies the trans-Golgi
network that was taken as a reference to distinguish between centripetal
and centrifugal movements. (d) Single particle tracking of the vesicle
shown in panel a during the 60 s with higher time resolution (1 s). The
starting and end points are indicated by arrowheads. Note the reversal
in direction at point R. (e) Instantaneous velocities of vesicle shown in
panels c and d versus time. The diagram distinguishes between centripetal
(toward the TGN, negative values) and centrifugal (away from the TGN,
positive values) movements of the vesicle. Velocities below 0.3  m/s
(marked by horizontal lines) were counted as Brownian motion rather
than motor-driven movement and not used in the subsequent statistical
analysis. 
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MARK2 expression where the microtubule network was still
intact. Fig. 3 a shows the punctate distribution of MARK2. The
microtubule network is still intact, and there is no sign of colo-
calization of MARK2 with microtubules (Fig. 3 b).
Exocytotic vesicles can be visualized by GFP-tagged
VSV-G protein (Scales et al., 1997). Fig. 3 (c–e) shows an ex-
ample of a particle moving initially to the cell center, then re-
versing to the periphery. In the motion analysis we record the
direction, instantaneous velocity, run length, and the frequency
of reversals (Trinczek et al., 1999). The outbound motion de-
pends essentially on the plus-end motor kinesin, inbound mo-
tion on the minus-end motor dynein. Elevation of MAPs such
as tau leaves the velocity unchanged (around 1 
 
 
 
m/s) but
strongly reduces the run length and reversal frequency. This
holds for both kinesin and dynein, but the inhibition of kinesin
is more severe so that dynein-driven movements become domi-
nant. Because the affinity of MAPs to microtubules is regulated
by phosphorylation these observations suggest that vesicle
movement should be regulatable by kinases causing the detach-
ment of MAPs from microtubules.
Indeed, when MARK2 is induced by addition of doxycy-
clin in CHO cells there is a dramatic effect on vesicle behavior
(Fig. 4). The predominant MAP in CHO cells is a variant of
MAP4, one of the high-molecular weight MAPs that control
microtubule dynamics (Bulinski and Borisy, 1980; Olson et al.,
1995). If the endogenous MAP4 represents obstacles to vesi-
cles on the microtubule track the detachment of MAP4 should
facilitate movement. This is indeed seen in the representative
traces of Fig. 4 a. The distances traversed during the observa-
tion time are normally small (a few micrometers) because there
are many kinks where the vesicles change direction. However,
induction of MARK2 leads to much more extended tracks (Fig.
4 b). The instantaneous velocities are not affected by MARK
(
 
 
 
1 
 
 
 
m/s; Fig. 4 c), but the reversal frequencies decrease by
 
 
 
50% (Fig. 4 d), and the run lengths increase by 
 
 
 
50% in both
directions (Fig. 4 e). Because MARK2 phosphorylates MAP4
or other MAPs at KXGS motifs in the repeat domain and de-
 
Figure 4.
 
Influence of MARK2 on the transport of vesicles and organelles.
 
(a) Tracking pattern of GFP-VSVG–tagged vesicles in noninduced CHO
cells (controls) and (b) in MARK2-induced CHO cells. Dots connected by a
line identify consecutive positions of a vesicle (1-s time intervals, arrow-
heads indicate starting points). The coordinates are centered on the TGN
(labeled strongly with GFP-VSVG) near the microtubule organizing center.
Upon MARK induction the tracks become longer and straighter, indicating
that fewer directional changes occur. (c–e) Quantification of GFP-VSVG–
tagged vesicle movement in noninduced CHO cells (black bars) and
MARK2-induced cells (gray bars). The data are based on the vesicle motion
recorded from 30 cells, 150 vesicles were analyzed, error bars 
 
 
 
 SEM.
(c) Velocities remain unchanged after the induction of MARK2 in either
direction (inbound v
 
 
 
0.9
 
 
 
m/s, outbound 
 
 
 
0.7 
 
 
 
m/s; 
 
n
 
 
 
 
 
 500). (d) Rever-
sal frequencies decrease strongly after MARK2 induction (
 
 
 
0.04 s
 
 
 
1
 
 with
MARK2, 
 
 
 
0.09 s
 
 
 
1
 
 without MARK2, both for inbound/outbound and out-
bound/inbound reversals; 
 
n 
 
 
 
 100). (e) Run lengths increase strongly
(
 
 
 
50%) upon MARK2 induction in both directions (
 
n
 
 
 
 
 
 100). Note that
both with and without MARK2 the inbound run lengths are 
 
 
 
30% longer
than outbound (4.6 
 
 
 
m inbound, 3.6 
 
 
 
m outbound without MARK2). (f and
g) Motion of lysosomes. (f) This panel shows an overlay of 60 images sep-
arated by 1 s. Lysosomes move on linear tracks 
 
 
 
1 
 
 
 
m (arrows). Particles
that are immobile or show only short Brownian movements (
 
 
 
0.3 
 
 
 
m and
random direction) can also be observed (spots marked by arrowheads).
(g) Velocities remain unchanged upon MARK2 induction (
 
 
 
0.8 
 
 
 
m/s),
but run lengths increase (from 3 to 5 
 
 
 
m). Reversal frequencies and direc-
tionalities cannot be determined because in CHO cells labeled with
LysoTracker there is no internal reference indicating the cell’s interior. (h)
Endocytotic vesicles: CHO cells were transiently transfected with EGFP-
labeled 
 
 
 
2-adaptin, a marker of the AP-2 complex of endocytotic clathrin-
coated vesicles. During the time of observation shown here (90 s) fluores-
cent paths are clearly visible. Linear or curved tracks longer than 1 
 
 
 
m
represent actively transported vesicles (arrows), broader black or gray
spots represent immobile particles and/or vesicles showing Brownian motion
(arrowheads). The overexpression of GFP/
 
 
 
2-adaptin causes a strong
background noise in the cytoplasm and the nucleus (N) becomes visible.
The rather immobile fluorescent patches in the more peripheral regions of
the cell are clathrin-coated vesicles or their precursors (arrowheads;
Laporte et al., 1999). In the interior of the cell near the nucleus (N) an
accumulation of the fluorescent signal can be observed suggesting that
EGFP/
 
 
 
2-adaptin also colocalizes with the exocytotic and/or endosomal
compartment. This is supported by the occurrence of fast moving vesicles
entering or leaving this area. In contrast to the post-Golgi vesicles labeled
by transient transfection of GFP-VSVG, the system here cannot provide
reversal frequencies because of the strong background that shortens the
time in which the particles are clearly seen in focus. (i) Velocities remain
unchanged by MARK2 (
 
 
 
1 
 
 
 
m/s), but run lengths increase almost two-
fold. The tracks illustrate three scenarios: the period of motion observed
within the plane of focus is flanked by (1) periods of active transport out of
focus, (2) resting states in focus and active transport out of focus, and (3)
periods of pauses in focus. We only analyzed events of movement which
were clearly in focus and which show at least two stop events in order to
determine the run length. As in the case of lysosomes (g), the velocity of
vesicles (i) remains roughly the same after MARK2 induction, but there is a
notable increase in the run length. Error bars indicate SEM. 
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taches them from microtubules (Illenberger et al., 1996), these
results argue that vesicle movement is facilitated and can in-
deed be regulated locally on the microtubule surface by MAP
phosphorylation. This effect is opposite to the transport inhibi-
tion by elevated MAP expression (demonstrated in Fig. 1 by
the clustering of mitochondria), so that MAPs and their kinases
can be regarded as antagonistic with respect to microtubule-
based vesicle trafficking.
To check whether the movements of other types of vesi-
cles or organelles were similarly affected by inducing MARK2
and subsequent phosphorylation of MAPs, we studied lyso-
somes and mitochondria labeled with fluorescent dyes. Gener-
ally, organelles differ from vesicles in that they spend only a
small fraction of their time (
 
 
 
10%) undergoing directed move-
ment, whereas the majority of time is spent with no motion or
only Brownian motion (local fluctuations 
 
 
 
0.3 
 
 
 
m/s; Trinczek
et al., 1999). Fig. 4 f shows an overlay of lysosomes during an
observation time of 60 s. Linear tracks of dots represent di-
rected motion, clusters of dots show Brownian motion, and sin-
gle dots correspond to particles sitting still. When analyzing
moving particles (Fig. 4 g), we find that the instantaneous ve-
locity is independent of whether MARK is induced or not
(
 
 
 
0.8 
 
 
 
m/s), but the run length rises conspicuously (approxi-
mately twofold). A similar behavior is found for mitochondria
(unpublished data). This means that organelles respond to
MARK induction similarly to exocytotic vesicles by increasing
the run length but not the local velocity. We further investi-
gated endocytotic vesicles labeled with GFP-
 
 
 
2-adaptin, one
of the cofactors of the AP-2 adaptin complex of clathrin-coated
vesicles (Laporte et al., 1999). Because of their high mobility
these vesicles generated a strong background throughout the
cytoplasm, and they frequently left the plane of focus which
made tracking difficult (Fig. 4 h). In the analysis (Fig. 4 i) we,
therefore, included only particles moving within the focal
plane, with defined start and stop points. Nevertheless, the
same picture emerged: MARK induction had almost no effect
on the instantaneous velocity (
 
 
 
1.1 
 
 
 
m/s) but increased the
run length by almost twofold (from 3 to 5 
 
 
 
m).
 
Effect of MARK on axonal transport
 
The results described thus far were derived from CHO cells be-
cause these cells are readily transfected, the microtubule net-
work can be observed, and the proteins are accessible to bio-
chemical analysis. However, for observing effects of transport
inhibition that may matter in neurodegeneration we had to turn
to differentiated neurons. After a search for suitable cell types
we focused on chicken RGCs. Explants of these cells can be
obtained from chicken retinae and develop numerous axons in
culture with a well-defined polarity which facilitates the mea-
surement of vesicle and organelle movements. The cells can
also be transfected with high efficiency (80%) using adenoviral
vectors, enabling one to observe the effects of tau (tagged with
CFP), MARK2 (tagged with YFP or CFP), and organelles visu-
alized by live stains. In the following description we focus on
two examples, mitochondria (stained with MitoTracker red)
and vesicles carrying APP, because APP, like tau, plays a cru-
cial role in AD. They are clearly visualized by confocal micros-
copy and the influence of tau or MARK2 are easily quantified.
One aim of the experiments is to demonstrate the correla-
tion between MARK activity, tau phosphorylation, and or-
ganelle movements in the same cell. In the RGC axons of Fig.
5 mitochondria show a roughly uniform distribution with a
density around 0.17 particles/
 
 
 
m (Fig. 5 a). Most of these
(55%) move anterogradely while the growth cone is advancing;
smaller fractions move retrogradely (
 
 
 
26%) or are stationary
during the period of observation (24 min; Fig. 5 j). When these
cells are transfected with CFP-tau the characteristics of move-
ment change dramatically: over the time of 24 h, most mito-
Figure 5. Distributions of mitochondria in
RGC axons, 48 h after transfection with Tau
by adenovirus. (a–c) Field of axons stained
with MitoTracker (a), CFP-Tau (b), and merge
(c). Mitochondria are frequent in normal axons,
but have almost disappeared from tau-trans-
fected axons (see bottom axon in b and c,
blue, closed arrowheads). (d–f) Expression of
tau with time after transfection, and (g–i)
corresponding clustering of mitochondria in
cell body. Tau gradually moves out into the
axon, whereas mitochondria accumulate in
the cell body. (j and k) Quantification of mito-
chondria movements in controls (j) and tau-
transfected cells (k). In control cells, antero-
grade movements dominate (55%, dark blue
bar), in tau-transfected cells anterograde trans-
port decreases (to 7%), immobile particles in-
crease (to 50%, red bar), and retrogradely
moving particles increase (to 45%, light blue
bar). Error bars indicate SEM. 
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chondria leave the axon and accumulate in the cell body be-
cause the dynein-mediated retrograde traffic dominates (Fig. 5,
d–i). The density of mitochondria in the axons decreases
strongly (0.08 particles/
 
 
 
m after 24 h; Fig. 5 c, arrow), the
fraction of anterograde movements drops below 10%, and sta-
tionary or retrograde particles increase to nearly 50% (Fig. 5
k). This feature corresponds to the clustering of mitochondria
in the cell body around the MTOC for CHO or N2a cells (Fig.
1, b, d, and f), and analogous observations apply to other cell
organelles (e.g., lysosomes, peroxisomes) or transport vesicles
(e.g., APP-containing vesicles; Stamer et al., 2002). Note that
in spite of the retrograde flow of mitochondria, the expressed
tau can move forward and fills the axon homogeneously, illus-
trating that the transport of tau (which is part of slow axonal
transport; Mercken et al., 1995) differs from the fast axonal
transport of vesicles and organelles.
The next question was whether the inhibitory effect of tau
could be relieved by removing tau from microtubules. We
transfected RGCs with CFP-tau and YFP-MARK2, both pro-
teins were expressed and became distributed along the axons
(Fig. 6 a, 1–3). This has striking consequences for mitochon-
drial movements (Fig. 6 b): anterograde movements became
substantially reactivated (
 
 
 
30%); the fraction of stationary
particles decreased (compare Fig. 6 b with Fig. 5 k); and the
density of particles increased again. A strong reaction of the
12E8 antibody appeared, revealing that tau was phosphorylated
at the KXGS motifs (Fig. 6 c, 2). The phosphorylation of tau
was accompanied by its removal from microtubules: if cells
transfected with tau and MARK2 (Fig. 6 d, 1) were extracted
with Triton X-100 the reaction with antibody 12E8 was lost
(Fig. 6 d, 3), indicating that the phosphorylated tau was indeed
detached from microtubules, and only traces of unphosphory-
lated tau remained in the axon (Fig. 6 d, 2). This is in strong
contrast to cells not transfected with MARK where extraction
by Triton X-100 does not remove tau from microtubules (Fig. 6
e, 1) and tau remains unphosphorylated at KXGS motifs (Fig. 6
e, 2). We conclude that the blockade of traffic was relieved af-
ter removing tau from the tracks by phosphorylation at the
Figure 6. Recovery of anterograde move-
ments of mitochondria by coexpression of tau
and MARK2. (a,1–3) Axons of RGCs stained
for mitochondria (MitoTracker, a 1), CFP-tau
(a 2), YFP-MARK2 (a 3). Numerous mitochon-
dria are present in axons, in spite of the
presence of tau, because the phosphorylation
of tau by MARK detaches it from microtubules
and facilitates transport (closed arrowheads).
(b) Velocity histogram of mitochondria. Note
the substantial recovery of anterograde trans-
port (dark blue bars) after coexpression with
MARK2 (compare with Fig. 5 k, transfection
of tau only). Error bars indicate SEM. (c, 1–4)
Axons showing YFP-MARK2 (c 1) and phos-
pho-Tau (at KXGS motifs, antibody 12E8, c 2,
closed arrowheads). Axons after transfection
with inactive CFP-MARK2 (c 3), which fails to
increase the phosphorylation of KXGS motifs
of tau (c 4, antibody 12E8 shows only back-
ground staining). (d, 1–3) Axons after trans-
fection of cells with YFP-MARK2 (d 1) and
then extracted with Triton X-100 and stained
for total Tau (antibody K9JA, d 2) phospho-
Tau (antibody 12E8, d 3). Note that Tau
phosphorylated at KXGS motifs disappears
because it is not attached to microtubules
(closed arrowheads). (e, 1 and 2) Axons not
transfected with MARK, extracted with Triton
X-100, show strong staining with Tau (K9JA,
e 1) but not with phospho-Tau (12E8, e 2). 
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KXGS motifs. Thus, MARK counteracts the inhibitory effect
of tau. This interpretation was checked by several controls.
Transfection of RGCs with GFP had only a minor effect, most
mitochondria moved anterogradely (
 
 
 
50%), only a small frac-
tion were in the pause state (
 
 
 
30%), underscoring that GFP is
a neutral marker (unpublished data). The same was true for the
kinase-dead mutant of MARK2 (Fig. 6 c, 3), indicating that the
effect of MARK was due to its kinase activity. Like active
MARK2 or GFP, the inactive mutant was also distributed
evenly along the axon (Fig. 6 c, 3), and there was no phosphor-
ylation of tau in the repeat domain above background (judging
by 12E8 immunofluorescence; Fig. 6 c, 4). Finally, we con-
structed an adenovirus vector encoding a mutant CFP-tau
where all four KXGS motifs were changed into KXGA so that
the targets of MARK2 were eliminated. Transfection in RGCs
caused a strong inhibition of transport, similar to wild-type tau
(compare Fig. 7, a and d with Fig. 5, j and k). However, in this
case the cotransfection with MARK2 was not able to induce
phosphorylation of tau or to rescue the mobility of mitochon-
dria (compare Fig. 7, b, c, and e with Fig. 6 b), showing that
blockage of traffic by tau and rescue by MARK2 requires
phosphorylatable KXGS motifs on tau.
Similar results on traffic inhibition were obtained with
APP-vesicles (labeled with YFP) as a function of tau and
MARK. In control RGCs, the majority of APP vesicles (80%)
moved rapidly anterogradely with velocities up to 7 
 
 
 
m/s, a
small fraction (
 
 
 
20%) moved retrogradely, and only very few
were in a pause state during the period of observation (20 min;
Fig. 8). Expression of tau reversed the net flow of APP vesicles
so that very few particles remained in the axons after 24 h (only
Figure 7. Non-phosphorylatable tau blocks
traffic and cannot be relieved by MARK2. (a)
RGC axon transfected with CFP-tau/KXGA
lacking phosphorylation sites by MARK (top,
blue). Most mitochondria are immobile (com-
pare arrowheads in middle and bottom panels).
(b) Axons transfected with CFP-tau/KXGA and
YFP-MARK2 (first and second panel). Mitochon-
dria are still immobile, despite the presence of
MARK2 (panels 3 and 4). (c) Axon trans-
fected with CFP-tau/KXGA (top, blue) and
YFP-MARK2 (middle, yellow), stained with
antibody 12E8 (bottom, red). Note that 12E8
reaction has disappeared because the KXGS
motifs are absent. (d) Histogram of mitochon-
dria mobility in tau/KXGA transfected cells
(see panel a, showing that  80% are immo-
bile, only a minority moves antero- or retro-
gradely. (e) Histogram of mitochondria mobility
in tau/KXGA and MARK2 transfected cells,
showing that MARK2 does not rescue mobility
when tau cannot be phosphorylated. Error
bars indicate SEM. 
MARK, MAPS, AND INTRACELLULAR TRANSPORT • MANDELKOW ET AL.
 
107
 
 
 
30% anterograde movements). However, coexpression of tau
and MARK2 lead to a partial rescue of the traffic inhibition, the
number of vesicles in the axons increased and the net flow be-
came anterograde again (
 
 
 
60% of particles). This reversal was
not seen with the kinase-dead MARK2 mutant or with the
KXGA-tau mutant.
 
Discussion
 
The path of vesicles and organelles through the cytoplasm de-
pends on multiple factors, tracks, motors, adaptors, address
codes, and random fluctuations. For most particles, and particu-
larly for long-haul traffic, microtubules are the predominant
tracks, mediated by microtubule motors such as kinesin or dy-
nein and their corresponding adaptors (Lippincott-Schwartz,
1998; Baas, 2002). In nonneuronal cells with a radial microtu-
bule network transport events are often highly irregular: the
lengths of coherent runs may be limited by obstacles and
Brownian fluctuations, und particles may contain several types
of motor protein competing with each other and with different
tracks. For cells with compact shapes (e.g., CHO) some lack of
fidelity in transport may be tolerable because particles tend to
recognize and dock to their destination via receptors and adap-
tor complexes, irrespective of whether the encounter results
from directed or undirected movements. In this scenario, micro-
tubules and their motors impose a directional bias but are not
unique determinants. However, directed transport becomes im-
portant with asymmetric cells such as neurons where diffusion
alone would not suffice to deliver particles to the nerve endings.
How can a cell regulate the directional bias? In the first in-
stance this is achieved by the architecture of the polar tracks and
the choice of motors and adaptors. Many studies have shown that
directed transport can be upset by interfering with microtubule
stability or orientation (Morris and Hollenbeck, 1995). Likewise,
inactivation or detachment of motors from their tracks or cargoes
leads to loss of motion or predominance of other motors (Tanaka
et al., 1998; Rahman et al., 1999; Morfini et al., 2002). A further
level of traffic control is the quality of the track surface and the
MAPs attached to it. Particle motility can be influenced by dif-
ferent types of MAPs (Sato-Harada et al., 1996; Bulinski et al.,
1997; Ebneth et al., 1998; Stamer et al., 2002). This effect tends
to be inhibitory because the MAPs occlude the binding sites for
motors on microtubules, as seen more directly by single-mole-
cule assays (Seitz et al., 2002). The inhibition leads to an overall
bias of particle flow toward the cell interior (Fig. 1).
What are the implications of the control chain linking
MARK with tau, microtubules, and motors? Because microtu-
bules and tau are present in neuronal cell bodies and axons, the
same distribution would be expected for MARK and its activat-
ing kinase, which is indeed observed (Timm et al., 2003). After
phosphorylation, the detached tau could float in the cytosol (as
seen by the diffuse fluorescence of CFP-tau), but in addition
the phospho-tau partly attaches to the actin cytoskeleton (Bier-
nat et al., 2002). A similar phenomenon has been reported for
phosphorylated MAP2c in dendrites (Ozer and Halpain, 2000).
A further point concerns the interference between motors and
tau on the microtubule surface. We previously reported that
bound tau reduces the average run length of vesicles in cells
(Trinczek et al., 1999), and here we show that MARK increases
the run length again. This would imply that MARK clears
MAPs off the microtubule tracks, either throughout the cell, or
at least locally, for example if MARK were bound to the cargo
to be transported. In that case the MAPs could mostly remain
associated with microtubules, and only a small fraction would
Figure 8. Recovery of anterograde transport of APP vesicles after coex-
pression of tau and MARK2. (a–c) RGC axon transfected with CFP-tau (a),
YFP-MARK2 (b), and APP-mRFP (c). The time series in panel c shows recov-
ery of anterograde movements. Open and closed arrowheads show two
vesicles moving to the right at different speeds. (d) Histogram showing
APP vesicle movements in control (left), after tau transfection (middle), after
cotransfection of tau and MARK2 (right). In control cells almost all vesicles
are mobile, and anterograde movements dominate. After tau transfection
 40% of vesicles become immobile, and the net flow becomes retro-
grade. MARK2 partially relieves the inhibition by tau, the net flow becomes
anterograde again. 
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need to be lifted locally from the microtubule surface. In addi-
tion we know from experiments on single motor molecules that
in vitro tau does not decrease the run length of kinesin as such
but the attachment frequency (Seitz et al., 2002). This apparent
discrepancy with the observations in cells can be explained by
assuming that a cargo particle contains several motors which
operate additively or even in concert (Vale, 2003). Thus if one
motor slips off the track, another could take over; but if the at-
tachment rate is lowered by a MAP the coordination is per-
turbed, resulting in a shorter run length.
In RGC axons the relationship between MARK, tau, and
traffic is more easily observable than in CHO cells because the
microtubule polarity is unambiguous, and traffic events can be
traced over longer distances and time periods. The main five
results for the case of mitochondria are as follows. (1) Normal
state: the majority of mitochondria move anterogradely, small
fractions move retrogradely or pause, and the density of mito-
chondria is relatively high (Fig. 5, a and j). (2) After tau trans-
fection the density decreases drastically (because most mito-
chondria accumulate in the cell body; Fig. 5, a, c, and d–i). The
remaining axonal mitochondria are mostly stationary, some
move back, and only very few still move anterogradely (Fig. 5
k). The final state is an axon nearly devoid of mitochondria and
thus vulnerable to oxidative stress and other insults (Stamer et
al., 2002). (3) Additional transfection of the cells with MARK
partially relieves the inhibition by tau so that organelles can
move more freely again, especially in the forward direction
(Fig. 6 b; Fig. 8). (4) The MARK-transfected axons show tau
phosphorylated at KXGS sites and extractable by Triton X-100,
indicating that tau is detached from microtubules (Biernat et
al., 2002; Fig. 6 c, 2 and d, 2 and 3). (5) Mutant tau with un-
phosphorylatable KXGA motifs induces strong transport inhi-
bition, which cannot be rescued by MARK2 (Fig. 7).
MAPs are often considered as static elements stabilizing
microtubules, with additional functions such as cross-linking,
spacing, or anchoring of other cell constituents. The dynamic
behavior of MAPs is usually considered only within the frame-
work of microtubule growth or shrinkage. In cells, MAPs are
predominantly bound to microtubules, supporting the notion of
structural elements (Cassimeris and Spittle, 2001). Nevertheless,
the redistribution of MAPs among microtubules is remarkably
dynamic even when there is no change in overall microtubule
polymerization, suggesting that there is a rapid on/off equilibra-
tion (Olmsted et al., 1989; Bulinski et al., 2001). The major reg-
ulation of MAP-microtubule binding is achieved by phosphory-
lation. Many protein kinases and phosphorylation sites have
been described for MAPs, most of which tend to lower their af-
finity to microtubules. Phosphorylation of MAPs is enhanced in
fetal tissue (when microtubules are more dynamic), in mitosis
(when microtubules have to rearrange), during neuronal differ-
entiation, and in pathological conditions such as neurodegenera-
tion in Alzheimer’s disease (where tau loses the ability to bind
and stabilize microtubules due to hyperphosphorylation; Lee et
al., 2001). These observations have focused attention on the role
of MAP phosphorylation in modulating microtubule stability.
However, because MAPs also occupy space on the tracks of mo-
tor proteins it seemed possible that the phosphorylation of
MAPs had other functions as well. MAPs, in particular tau, can
be phosphorylated by many kinases, and most target sites be-
come highly phosphorylated in Alzheimer’s disease and related
tauopathies. However, the effects of tau phosphorylation at dif-
ferent sites can be quite variable. The target sites of proline-
directed kinases (SP or TP motifs) tend to have weak or moder-
ate effects, whereas the KXGS motifs in the repeat domain have
a pronounced ability to detach tau from microtubules. Tau’s
ability to interfere with transport requires microtubule binding
(Seitz et al., 2002). Therefore, it appeared that MARK would be
a good candidate for reversing the transport inhibition.
There are four kinases of the MARK family in humans
(Manning et al., 2002). They phosphorylate the KXGS motifs
in the MAP2/MAP4/tau family in a similar fashion (Drewes et
al., 1997). MARK and its homologues (e.g., PAR-1 in 
 
C. ele-
gans
 
 and 
 
Drosophila
 
) are important in establishing asymmetric
cell shapes and distributions (Kemphues, 2000; Riechmann and
Ephrussi, 2001; Cohen et al., 2004), including NGF-induced
neurite outgrowth from neurons (Biernat et al., 2002). The ef-
fects of MARK would therefore be visible in various cell types.
MARK is itself regulated by phosphorylation of the activation
loop by the activating kinase MARKK (Timm et al., 2003). It is
thus embedded in a kinase cascade, reminiscent of other cas-
cades that are regulated by intra- or extracellular signals (Cobb
and Goldsmith, 2000). Other modes of regulation could be
through scaffold proteins such as 14-3-3 (Benton et al., 2002).
The triggers of MARK signaling are not well understood, but
they appear to include neuronal differentiation signals and oxi-
dative stress (Jenkins and Johnson, 2000; Biernat et al., 2002).
The results summarized in Fig. 9 show that the cell is ca-
pable of enhancing the motility of vesicles and organelles by ac-
tivating the kinase MARK2. This kinase mainly targets the
KXGS motifs in MAP4, MAP2, and tau, thereby removing
them from the microtubule surface. Conversely, overexpression
of MAPs overwhelms the kinase and leads to clogging of tracks
and traffic inhibition, independently of the stabilization of mi-
crotubules. It is possible that this kinase also explains the phos-
phorylation-induced enhancement of vesicle motility observed
by other authors (Lopez and Sheetz, 1995; Sato-Harada et al.,
1996). The mechanism appears to be similar with all cargoes
and MAPs studied so far (demonstrated here for the case of
VSV-G vesicles, clathrin-coated vesicles, APP-vesicles, lyso-
somes, and mitochondria; Figs. 4, 6, and 8). It is based on an ap-
parent extension of the run length without change in the instan-
taneous velocities. This means that the motor activity itself is
not affected, but the probability of motor attachment is in-
creased because there are fewer MAPs as obstacles in their way.
MARK was originally identified by a search for the ki-
nase that phosphorylates tau at sites that appear at early stages
of Alzheimer’s neurodegeneration and that are critical for tau’s
binding and stabilization (Augustinack et al., 2002). In Alzhei-
mer’s disease, two proteins are mainly responsible for the ab-
normal aggregates, tau and the A
 
 
 
 peptide, whose relationship
is still a matter of debate. The observation that tau inhibits ax-
onal traffic, including that of APP, may shed new light on the
relationship. If APP remains in the cell body for extended peri-
ods because anterograde traffic is blocked by tau there is a 
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higher probability of intracellular cleavage of APP and genera-
tion of A
 
 
 
 peptides which are toxic for the neuron. We specu-
late that the cell responds to this challenge by activating the ki-
nase MARK which would free up the intracellular pathways
and thereby reduce the generation of A
 
 
 
. Thus, the early phos-
phorylation of tau at KXGS motifs observed in Alzheimer’s
disease could be seen as the cell’s defense strategy to keep
traffic pathways open and to reduce the generation of toxic
byproducts. This mechanism would provide an interesting op-
portunity for identifying factors that cause the degeneration of
neurons, and for designing methods to relieve it. Finally, we
note that there is increasing evidence that neurodegeneration is
accompanied by defects in transport. This could be due to a de-
fect or an unbalance of motors, adaptors of cargoes, or tracks
and their modifiers, as in the case described here (for review
see Goldstein, 2003). The mechanisms and responsible pro-
teins may differ, but the common principle is that even slight
perturbances of the traffic system has severe consequences for
neurons whose survival depends on active transport.
 
Materials and methods
 
Plasmids, cell culture, transfection, and fluorescent labeling
 
cDNAs encoding MAP2c, MAP4-BD, and MARK2 were inserted into
a derivative of pRc/CMV (Invitrogen) using synthetic linkers, which in-
troduced an NH
 
2
 
-terminal HA-epitope tag, to yield pEUHAMAP2c,
pEUHATagMAP4-BD (provided by J. Olmsted, University of Rochester,
Rochester, NY; Ebneth et al., 1999) and pEUHATagMARK2 (Drewes et
al., 1997). For doxycyclin-inducible expression, epitope-tagged MARK2
was cloned into pUHD10-3 to yield pINDMARK2 (Drewes et al., 1997).
pUHD10-3 were provided by H. Bujard (ZMBH, Heidelberg, Germany).
Stably transfected MARK2-inducible CHO cells (CHO-I3) were cloned as
described previously (Drewes et al., 1997). Induction of MARK2 was
achieved by addition of 1 
 
 
 
g/ml doxycyclin (Sigma-Aldrich) into the me-
dium and incubation for 12–18 h. Induction of HA-tagged MARK2 in
cells prepared for motion analysis was checked by immunofluorescence.
Cells seeded on coverslips were fixed with 2% (wt/vol) PFA. Primary an-
tibody incubation was performed in PBS, 3% goat serum for 1 h at 37
 
 
 
C
(polyclonal rabbit HA tag antibody; MoBiTec; tubulin antibody DM1A;
Sigma-Aldrich). Fluorescently labeled secondary antibodies were applied
at 1:200 dilution for 1 h at 37
 
 
 
C (Dianova). Cells were then sealed with
permafluor (Dianova) and analyzed under an Axioplan microscope (Carl
Zeiss MicroImaging, Inc.) equipped with an 100
 
 
 
 oil immersion objec-
tive (Carl Zeiss MicroImaging, Inc.) using standard FITC and TRITC filters.
Cells were grown in Ham’s F12 medium with 10% FCS and 2 mM gluta-
mine (Biochrom) at 37
 
 
 
C and 5% CO
 
2
 
 in a humidified chamber. For tran-
sient transfection of the CHO-I3 cells with GFP-VSVG plasmid (provided
by S. Scales and T. Kreis, University of Geneva, Geneva, Switzerland;
Scales et al., 1997) and with GFP-
 
 
 
2-adaptin plasmid (provided by S.
Laporte and M. Caron, Duke University, Durham, NC; Laporte et al.,
1999), cells were seeded at 70% confluency onto LabTek chambered
cover glass (Nunc) and transfected with 1 
 
 
 
g of plasmid DNA in the
presence of DOTAP (Boehringer) following the manufacturer’s instruc-
tions. Lysosomes and mitochondria were fluorescently labeled by 1 
 
 
 
M
LysoTracker or 200 nM MitoTracker red (Molecular Probes) for 15 min.
For fluorescent staining of the AP-2/clathrin-coated vesicles, cells
were transfected overnight with 1 
 
 
 
g of the EGFP/
 
 
 
2-adaptin vector (
 
 2-
adaptin gene cloned into the SmaI–BamHI site of pEGFP-C1 (CLONTECH
Laboratories, Inc.) using DOTAP (Boehringer). Before data acquisition the
chamber was sealed with baysilone (Bayer) to keep the pH of the culture
medium constant at pH 7.2–7.4. Temperature was held constant at 35 C
by an air stream. Samples were observed with an Axiovert 10 (Carl Zeiss
MicroImaging, Inc.) equipped with a 63 /1.4 NA oil-immersion objec-
tive and standard fluorescein filters.
Stable transfection of CHO cells
Stably tau transfected CHO cells were generated as described previously
(Ebneth et al., 1998). For expressing MAP2c or MAP4-BD in CHO cells,
 60% confluent CHO cells were transfected with 2  g of plasmid DNA
pEUHATagMAP4-BD or pEUHAMAP2c encoding MAP4-BD or MAP2c,
and Lipofectamine following the manufacturer’s protocol (Invitrogen Life
Technologies). Stably transfected cells were selected by growing them in
800  g/ml geneticin (G-418). After incubation for additional 2–3 wk,
cells were cloned by limiting dilution and screened for MAP4-BD–or
MAP2c-expressing cells by immunofluorescence and PCR.
Adenovirus vectors encoding fluorescent fusion proteins
Recombinant adenoviruses (CFP-htau40, nonphosphorylatable CFP-
htau40/KXGA, APP-YFP, APP-mRFP, YFP-MARK2 wild-type, or dominant
negative mutant CFP-MARK2/T208A/S212A) were generated following
He et al. (1998) (see Online supplemental material).
Live cell light microscopy
RGCs were prepared as described previously (Stamer et al., 2002; see On-
line supplemental material). For visualizing the transfection of RGCs and the
movement of vesicles and organelles the cells were observed on a confocal
microscope (model LSM510; Carl Zeiss MicroImaging, Inc.), kept at 37 C
by air heating and supplied with 5% CO2. Images were taken every 4 s for
tracking of vesicles and every 8 s for mitochondria, using a 63  objective,
beam path, and laser settings for YFP, CFP, or rhodamine fluorescence. Er-
ror bars in histograms indicate SEM throughout.
Antibodies and dyes
Rat monoclonal anti-tubulin antibody YL1/2 and mouse mAb DM1A were
purchased from Serotec and Sigma-Aldrich, and used at 1:2,000. Poly-
clonal rabbit anti tau-antibody K9JA was purchased from DakoCytoma-
tion, mAb 12E8 against tau (phosphorylated KXGS motifs in the repeat
domain, Ser 262 and 356) was a gift from P. Seubert (Elan Pharma,
South San Francisco, CA), antibodies against peroxisomes were from W.
Just (University of Heidelberg, Heidelberg, Germany). The clone of mRFP
was provided by R. Tsien (University of California, San Diego, La Jolla,
CA). All fluorescent (TRITC, FITC, and AMCA) secondary antibodies were
purchased from Dianova.
Immunofluorescence
Cells were fixed in methanol or 4% PFA and incubated with antibodies.
Cells were examined with an Axioplan fluorescence microscope (Carl
Zeiss MicroImaging, Inc.) equipped with an 100  oil-immersion objec-
tive and filters optimized for triple-label experiments (FITC-, TRITC-, and
AMCA-fluorescence) or with an LSM510 confocal microscope using a
63  objective. Changes in mitochondrial distribution were quantified by
measuring the cell area occupied by mitochondria, compared with the
whole cell, after subtracting the area occupied by the nucleus.
Online supplemental material
Online supplemental material describes the generation of adenoviruses
and the transfection of retinal ganglion neurons. This is available at http://
www.jcb.org/cgi/content/full/jcb.200401085/DC1.
Figure 9. Model of MAPs and MARK regulating the movement of motors
along microtubules. (Top) Unphosphorylated MAPs are attached to micro-
tubules and present obstacles to motors such as kinesin (short run length,
inhibition of attachment of motors). (Bottom) MAPs phosphorylated by
MARK detach from microtubules and thus clear the path for motors.JCB • VOLUME 167 • NUMBER 1 • 2004 110
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